<- Go Home
Sinobiopharma, Inc.
As of September 22, 2008, Sinobiopharma, Inc. was acquired by DongYing (Jiangsu) Pharmaceuticals Co., Ltd., in a reverse merger transaction. Sinobiopharma, Inc. focuses on the research, development, and production of biopharmaceuticals. The company is based in Nantong City, China.
Market Cap
$201.0M
Volume
350.4K
Cash and Equivalents
$2.0K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$2.25
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-9.2K
Price / Earnings
-2.8K
Price / Tangible Book Value
-9.2K
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$70.8K
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$2.0K
Debt
$8.7K
Equity
-$22.0K
Revenue
N/A
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium